Trial	Safety
	Serious AE	Reactogenicity	AE to discontinuation
RIX Anh 2011‐PHL	X	X	X
RIX Anh 2011‐VNM	X	X	X
RIX Bernstein 1998‐USA	X	X	X
RIX Bernstein 1999‐USA	‐	X	‐
RIX Colgate 2016‐BGD	‐	‐	‐
RIX Dennehy 2005‐NA	X	X	X
RIX GSK[021] 2007‐PAN	X	X	X
RIX GSK[033] 2007‐LA	X	X	X
RIX GSK[041] 2007‐KOR	X	X	X
RIX GSK[101555] 2008‐PHL	X	X	X
RIX Kawamura 2011‐JPN	X	X	X
RIX Kerdpanich 2010‐THA	X	X	X
RIX Kim 2012‐KOR	X	X	X
RIX Li 2013a‐CHN	X	X	X
RIX Li 2013b‐CHN	‐	‐	‐
RIX Li 2014‐CHN	X	X	X
RIX Madhi 2010‐AF	X	‐	‐
RIX Narang 2009‐IND	X	X	X
RIX NCT00158756‐RUS	X	‐	X
RIX Omenaca 2012‐EU	X	X	‐
RIX Phua 2005‐SGP	X	X	Xa
RIX Phua 2009‐AS	X	‐	X
RIX Rivera 2011‐DOM	X	X	‐
RIX Ruiz‐Palac 06‐LA/EU	X	X	X
RIX Salinas 2005‐LA	X	X	‐
RIX Steele 2008‐ZAF	X	X	X
RIX Steele 2010a‐ZAF	X	Xa	‐
RIX Steele 2010b‐ZAF	X	X	X
RIX Tregnaghi 2011‐LA	X	‐	X
RIX Vesikari 2004a‐FIN	X	X	X
RIX Vesikari 2004b‐FIN	X	X	X
RIX Vesikari 2007a‐EU	X	X	‐
RIX Vesikari 2011‐FIN	X	X	X
RIX Ward 2006‐USA		Xa	‐
RIX Zaman 2009‐BGD	X	X	‐
RIX Zaman 2017‐BGD	X	‐	‐
TEQ Armah 2010‐AF	X	Xa	X
TEQ Block 2007‐EU/USA	X	X	X
TEQ Ciarlet 2009‐EU	X	X	‐
TEQ Clark 2003‐USA	X	X	X
TEQ Clark 2004‐USA	Xa	X	X
TEQ Dhingra 2014‐IND	X	X	X
TEQ Iwata 2013‐JPN	Xa	X	X
TEQ Kim 2008‐KOR	X	Xa	‐
TEQ Lawrence 2012‐CHN	X	Xa	X
TEQ Levin 2017‐AF	X	X	X
TEQ Merck[009] 2005‐USA	X	X	X
TEQ Mo 2017‐CHN	X	X	X
TEQ Vesikari 2006a‐FIN	X	X	X
TEQ Vesikari 2006b‐INT	X	X	Xa
TEQ Zaman 2010‐AS	X	Xa	X
SIIL Isanaka 2017‐NER	X	X	‐
SIIL Kulkarni 2017‐IND	X	X	X
SIIL Zade 2014‐INDa	X	Xa	‐
SIIL Zade 2014‐INDb	X	X	‐
SIIL Zade 2014‐INDc	X	X	‐
VAC Bhandari 2006‐IND	X	X	‐
VAC Bhandari 2009‐IND	X	X	‐
VAC Bhandari 2014‐IND	X	‐	‐
VAC Chandola 2017‐IND	X	‐	‐